TrialClinical drug investigation2020

Safety, Pharmacokinetics, and Pharmacodynamics of Globalagliatin, a Glucokinase Activator, in Chinese Patients with Type 2 Diabetes Mellitus: A Randomized, Phase Ib, 28-day Ascending Dose Study.

Shuai Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.